PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts
PARP inhibitors niraparib and talazoparib are FDA approved for special cases of breast cancer. PARP is an interesting repair protein which is frequently affected in cancer cells. We studied the combined action...
20:775
BMC Cancer 2020
No hay comentarios:
Publicar un comentario